This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Aug;62(2):135-7.

doi: 10.1111/j.1365-2125.2006.02739_1.x.

Risk perception in drug therapy

PMID: 16842386
PMCID: PMC1885091
DOI: 10.1111/j.1365-2125.2006.02739_1.x

Editorial

Risk perception in drug therapy

J K Aronson. Br J Clin Pharmacol. 2006 Aug.

. 2006 Aug;62(2):135-7.

doi: 10.1111/j.1365-2125.2006.02739_1.x.

Author

PMID: 16842386
PMCID: PMC1885091
DOI: 10.1111/j.1365-2125.2006.02739_1.x

No abstract available

PubMed Disclaimer

Similar articles

[Drug side effect or negative placebo effect?].
Lapin IP. Lapin IP. Eksp Klin Farmakol. 2000 Sep-Oct;63(5):76-8. Eksp Klin Farmakol. 2000. PMID: 11109536 Russian. No abstract available.
[A symposium on drugs and adverse effects. Serious problems--but the debate needs balance].
Lennholm B. Lennholm B. Lakartidningen. 1996 Dec 11;93(50):4653-4, 4657. Lakartidningen. 1996. PMID: 8999263 Swedish. No abstract available.
Pharmacoepidemiology and drug safety.
[No authors listed] [No authors listed] Pharmacoepidemiol Drug Saf. 2004 Feb;13(2):117-32. doi: 10.1002/pds.915. Pharmacoepidemiol Drug Saf. 2004. PMID: 14998074 No abstract available.
Adverse drug interactions in dentistry.
Hersh EV, Moore PA. Hersh EV, et al. Periodontol 2000. 2008;46:109-42. doi: 10.1111/j.1600-0757.2008.00224.x. Periodontol 2000. 2008. PMID: 18201348 Review. No abstract available.
Communicating the risks and benefits of medicines.
Schmid EF, Smith DA, Ryder SW. Schmid EF, et al. Drug Discov Today. 2007 May;12(9-10):355-64. doi: 10.1016/j.drudis.2007.03.003. Epub 2007 Mar 23. Drug Discov Today. 2007. PMID: 17467571 Review.

See all similar articles

Cited by

Medication Risk Management.
Mohiuddin AK. Mohiuddin AK. Innov Pharm. 2019 Aug 31;10(1):10.24926/iip.v10i1.1647. doi: 10.24926/iip.v10i1.1647. eCollection 2019. Innov Pharm. 2019. Retraction in: Innov Pharm. 2020 Feb 25;11(1). doi: 10.24926/iip.v11i1.3937. PMID: 34007537 Free PMC article. Retracted.
Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital.
Mishra S, Swain TR, Mohanty M. Mishra S, et al. J Clin Diagn Res. 2013 Jun;7(6):1131-4. doi: 10.7860/JCDR/2013/4985.3041. Epub 2013 Jun 1. J Clin Diagn Res. 2013. PMID: 23905119 Free PMC article.
Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising.
Kelly BJ, Rupert DJ, Aikin KJ, Sullivan HW, Johnson M, Bann CM, Mack N, Southwell BG, West S, Parvanta S, Rabre A, Peinado S. Kelly BJ, et al. Res Social Adm Pharm. 2021 May;17(5):942-955. doi: 10.1016/j.sapharm.2020.07.028. Epub 2020 Aug 6. Res Social Adm Pharm. 2021. PMID: 32883618 Free PMC article.
Patients' Preferences for Generic and Branded Over-the-Counter Medicines: An Adaptive Conjoint Analysis Approach.
Halme M, Linden K, Kääriä K. Halme M, et al. Patient. 2009 Dec 1;2(4):243-55. doi: 10.2165/11314130-000000000-00000. Patient. 2009. PMID: 22273245
Diabetes patient's pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation.
Matos C, van Hunsel F, Tavares Ribeiro R, Nascimento do Ó D, Raposo JF. Matos C, et al. Ther Adv Drug Saf. 2020 Sep 4;11:2042098620953935. doi: 10.1177/2042098620953935. eCollection 2020. Ther Adv Drug Saf. 2020. PMID: 35173953 Free PMC article.

See all "Cited by" articles

References

1. Inman WHW. Risks in medical intervention. In: Cooper MG, editor. Risk: man-made hazards to man. Oxford: Clarendon Press; 1985. pp. 35–53. editor.
1. Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? BMJ. 2003;327:728–31. - PMC - PubMed
1. Harrabin R, Coote A, Allen J. London: King's Fund; 2003. Health in the News.
1. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf. 2005;28:851–70. - PubMed
1. Bongard V, Menard-Tache S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL. Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. Br J Clin Pharmacol. 2002;54:433–6. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information